Thiazolidine

Thiazolidine

SCHEMBL7869290

C1CSCN1.N

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Thiazolidine SCHEMBL5484388 0.96
Thiazolidine SCHEMBL131493 0.96
Thiazolidine SCHEMBL7360 0.96
Thiazolidine SCHEMBL2914331 0.93
Thiazolidine SCHEMBL2914332 0.93
Thiazolidine SCHEMBL25231396 0.93
Thiazolidine SCHEMBL9270747 0.93
Thiazolidine SCHEMBL6687453 0.93
Thiazolidine SCHEMBL2158442 0.93
Thiazolidine SCHEMBL9034521 0.93

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310180-B1 PEPTIDE BIOSYNTHESIS REQUIRING NEITHER PROTECTION NOR ACTIVE C-ALPHA CARBOXYL GROUPS BY COUPLING PEPTIDES BY REACTING A 1-AMINO-2-MERCAPTO ALKYL ATTACHED TO ONE PEPTIDE WITH THE CARBOXY GROUP OF THE OTHER; REARRANGEMENT; STABILITY VANDERBILT UNIVERSITY 2001-10-30 US disclosed
US-5589356-A CYCLIZATION VANDERBILT UNIVERSITY (US) 1996-12-31 US disclosed
WO-1995000846-A1 DOMAIN LIGATION STRATEGY TO ENGINEER PROTEINS WITH UNUSUAL ARCHITECTURES TAM JAMES P (US) 1995-01-05 WO disclosed